Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001730574-24-000001
Filing Date
2024-09-23
Accepted
2024-09-23 12:01:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 zura.htm SC 13G/A 52614
  Complete submission text file 0001730574-24-000001.txt   54353
Mailing Address 142 WEST 57TH STREET 11TH FLOOR, SUITE 09-126 NEW YORK NY 10019
Business Address 142 WEST 57TH STREET 11TH FLOOR, SUITE 09-126 NEW YORK NY 10019 646-813-2470
Athanor Capital, LP (Filed by) CIK: 0001730574 (see all company filings)

EIN.: 320520630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Subject) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92696 | Film No.: 241315483
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)